Drug intelligence / Profile preview

Qingfei Zhike Wan

Development stage: Unknown
Lead developer: Qinghai Jiumei Tibetan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Qingfei Zhike Wan is a traditional Tibetan medicine (TTM) formulated as oral pills. Developed and manufactured by Qinghai Jiumei Tibetan Medicine, it is an approved pharmaceutical product in China (National Medicine Standard/国药准字). The formulation is traditionally used to 'clear lung heat' and 'relieve cough,' targeting symptoms associated with respiratory conditions such as bronchitis, pneumonia, and chronic cough. As a multi-herb Tibetan formulation, its mechanism involves the synergistic effects of various botanical ingredients to reduce inflammation in the respiratory tract and facilitate expectoration.

Brand names: Jiumei
Other names: 清肺止咳丸Qingfei Zhike Pills

Beyond the preview

Go deeper on Qingfei Zhike Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingfei Zhike Wan.

Explore the full profile